Matches in Wikidata for { <http://www.wikidata.org/entity/Q38003501> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- Q38003501 description "article científic" @default.
- Q38003501 description "article scientifique" @default.
- Q38003501 description "articol științific" @default.
- Q38003501 description "articolo scientifico" @default.
- Q38003501 description "artigo científico" @default.
- Q38003501 description "artigo científico" @default.
- Q38003501 description "artigo científico" @default.
- Q38003501 description "artikel ilmiah" @default.
- Q38003501 description "artikull shkencor" @default.
- Q38003501 description "artículo científico" @default.
- Q38003501 description "artículu científicu espublizáu en 2012" @default.
- Q38003501 description "bilimsel makale" @default.
- Q38003501 description "scienca artikolo" @default.
- Q38003501 description "scientific article published on 17 April 2012" @default.
- Q38003501 description "scientific article published on 17 April 2012" @default.
- Q38003501 description "scientific article published on 17 April 2012" @default.
- Q38003501 description "vedecký článok" @default.
- Q38003501 description "vetenskaplig artikel" @default.
- Q38003501 description "videnskabelig artikel" @default.
- Q38003501 description "vitenskapelig artikkel" @default.
- Q38003501 description "vitskapeleg artikkel" @default.
- Q38003501 description "vědecký článek" @default.
- Q38003501 description "wetenschappelijk artikel" @default.
- Q38003501 description "wissenschaftlicher Artikel" @default.
- Q38003501 description "наукова стаття, опублікована у квітні 2012" @default.
- Q38003501 description "научная статья" @default.
- Q38003501 description "научни чланак" @default.
- Q38003501 description "מאמר מדעי" @default.
- Q38003501 description "مقالة علمية نشرت في 17 أبريل 2012" @default.
- Q38003501 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38003501 name "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 name "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 name "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 type Item @default.
- Q38003501 label "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 label "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 label "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 prefLabel "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 prefLabel "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 prefLabel "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 P1433 Q38003501-558DEA7D-0ED5-4222-B8B1-850737CB1A2A @default.
- Q38003501 P1476 Q38003501-043BE4A4-DA71-44DD-A969-37DAD894B32E @default.
- Q38003501 P2093 Q38003501-1EFE3AD5-644B-43AC-8D03-8DE0D285EEB2 @default.
- Q38003501 P2093 Q38003501-E9309F10-1B53-4B55-8B2B-76DD6357C8FD @default.
- Q38003501 P304 Q38003501-FBC3E7B7-0B3D-4C10-8128-E122BB61A563 @default.
- Q38003501 P31 Q38003501-E5D2FA4A-02E4-41D2-9515-204BC14D4F89 @default.
- Q38003501 P356 Q38003501-DA5E6D87-F7E1-4E6B-9ED3-1FCF5823F4A1 @default.
- Q38003501 P433 Q38003501-0AD26B70-9639-4479-9EA6-B854ED97EBD2 @default.
- Q38003501 P478 Q38003501-B3E1B6EF-550F-413C-AF9B-15FCC0FC529C @default.
- Q38003501 P577 Q38003501-C0EFF294-9D96-4B42-924E-E0F264EB47A7 @default.
- Q38003501 P698 Q38003501-B3565D95-FD91-4753-985F-237F31EF7B36 @default.
- Q38003501 P356 J.SEMARTHRIT.2012.03.004 @default.
- Q38003501 P698 22512815 @default.
- Q38003501 P1433 Q15761553 @default.
- Q38003501 P1476 "The use of Canakinumab, a novel IL-1β long-acting inhibitor, in refractory adult-onset Still's disease" @default.
- Q38003501 P2093 "Apostolos Kontzias" @default.
- Q38003501 P2093 "Petros Efthimiou" @default.
- Q38003501 P304 "201-205" @default.
- Q38003501 P31 Q13442814 @default.
- Q38003501 P356 "10.1016/J.SEMARTHRIT.2012.03.004" @default.
- Q38003501 P433 "2" @default.
- Q38003501 P478 "42" @default.
- Q38003501 P577 "2012-04-17T00:00:00Z" @default.
- Q38003501 P698 "22512815" @default.